0.7301
price down icon1.07%   -0.0079
 
loading
전일 마감가:
$0.738
열려 있는:
$0.73
하루 거래량:
59,679
Relative Volume:
0.39
시가총액:
$28.49M
수익:
$135.87M
순이익/손실:
$72.20M
주가수익비율:
0.5142
EPS:
1.42
순현금흐름:
$45.09M
1주 성능:
+0.70%
1개월 성능:
-2.52%
6개월 성능:
-31.77%
1년 성능:
-64.98%
1일 변동 폭
Value
$0.73
$0.7439
1주일 범위
Value
$0.701
$0.7439
52주 변동 폭
Value
$0.66
$2.21

Scynexis Inc Stock (SCYX) Company Profile

Name
명칭
Scynexis Inc
Name
전화
201-884-5485
Name
주소
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Name
직원
29
Name
트위터
@scynexis
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
SCYX's Discussions on Twitter

SCYX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
SCYX
Scynexis Inc
0.7301 28.80M 135.87M 72.20M 45.09M 1.42
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.12 68.04B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.48 46.30B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.88 44.25B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.54 18.73B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
304.50 13.82B 2.99B 1.21B 1.13B 25.06

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-01-22 개시 Guggenheim Buy
2021-01-06 개시 Cantor Fitzgerald Overweight
2018-07-11 업그레이드 Needham Hold → Buy
2018-06-27 개시 Maxim Group Buy
2017-10-24 개시 Guggenheim Buy
2017-07-10 개시 ROTH Capital Buy
2017-05-09 다운그레이드 Needham Buy → Hold
2017-03-03 재확인 RBC Capital Mkts Outperform
2016-10-20 개시 H.C. Wainwright Buy
2016-10-07 업그레이드 WBB Securities Buy → Strong Buy
2016-10-03 재개 Brean Capital Buy
2016-08-17 개시 Guggenheim Buy
2016-08-09 재확인 Needham Buy
2016-08-09 업그레이드 WBB Securities Speculative Buy → Buy
2016-03-28 개시 Brean Capital Buy
2015-12-29 개시 WBB Securities Speculative Buy
2015-11-16 재확인 RBC Capital Mkts Outperform
2015-06-10 개시 Needham Buy
2014-05-29 개시 Canaccord Genuity Buy
2014-05-29 개시 RBC Capital Mkts Outperform
모두보기

Scynexis Inc 주식(SCYX)의 최신 뉴스

pulisher
Jul 24, 2025

Is SCYNEXIS Inc. a good long term investmentTremendous growth opportunities - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What drives SCYNEXIS Inc. stock priceFastest return on investment - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about SCYNEXIS Inc. stockUnstoppable profit momentum - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

SCYNEXIS Inc. Stock Analysis and ForecastFast-track wealth growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 19, 2025

Is ATH.PRA a good long term investmentSkyrocketing returns - Jammu Links News

Jul 19, 2025
pulisher
Jul 16, 2025

What makes SCYNEXIS Inc. stock price move sharplyTop Analyst Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why SCYNEXIS Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How SCYNEXIS Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Scynexis Inc (SCYX) Stock: A Year of Highs and Lows in the Market - investchronicle.com

Jul 15, 2025
pulisher
Jul 02, 2025

SCYNEXIS Holds Annual Meeting, Re-elects Directors - The Globe and Mail

Jul 02, 2025
pulisher
Jun 26, 2025

SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price - TipRanks

Jun 26, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Buys New Holdings in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Biosergen taps antifungal expert as board member - Biostock

Jun 05, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Has $186,000 Stake in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 03, 2025
pulisher
May 29, 2025

Scynexis resumes dosing in Phase III MARIO study after lengthy delay - MSN

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold - Insider Monkey

May 29, 2025
pulisher
May 28, 2025

Scynexis resumes patient dosing in Phase 3 MARIO study - TipRanks

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing In Phase 3 MARIO Study - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX St - GuruFocus

May 28, 2025
pulisher
May 28, 2025

GSK Involved in SCYNEXIS's Phase 3 Study Milestone Dispute | GSK Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study - The Manila Times

May 28, 2025

Scynexis Inc (SCYX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$72.93
price up icon 2.82%
$14.92
price up icon 1.57%
$9.41
price up icon 0.64%
drug_manufacturers_specialty_generic RDY
$14.67
price down icon 0.27%
$132.14
price up icon 0.38%
$304.50
price down icon 0.62%
자본화:     |  볼륨(24시간):